The current study was designed to assess the expression level of three key glycolytic genes, HK2, PFKM, and PKM2, along with their association with clinicopathological parameters and molecular subtypes in breast cancer cohort of Pakistan. This evidence concerns the gene HK2 and breast carcinoma.